• mTor-inhibitor (EVERolimus) Based Immunosuppressive Strategies for CNI Minimisation in OLD for Old Renal Transplantation

  NCT01028092

  CompletedInterventionalPhase 3Updated Jul 8, 2014
• Renal Transplantation in the Elderly - nEverOld Study

  NCT01631058

  Unknown statusInterventionalPhase 4Updated Dec 4, 2015
• Everolimus bAsed caLcineurin inhibiTor frEe immunosuppRession oNe Year AfTer lIver transplantatiON (ALTERNATION)

  NCT07739914

  Not yet recruitingInterventionalPhase 3Updated Jul 31, 2026
• Study to Evaluate the Safety and Efficacy of Switching Calcineurin Inhibitor to Everolimus After Kidney Transplantation in Adults

  NCT01455649

  Unknown statusInterventionalPhase 4Updated Oct 20, 2011
• Study Evaluating the Benefit of Two Immunosuppressive Strategies on Renal Function

  NCT02334488

  CompletedInterventionalPhase 3Updated Jan 29, 2021
• Study of Everolimus in de Novo Renal Transplant Recipients

  NCT01609673

  TerminatedInterventionalNot ApplicableUpdated Jun 12, 2013

ClinicalTrials.gov ID

NCT06504225

Lead Sponsor

University Hospital, BrestOTHER

Overall Status

Recruiting

Study Type

Observational

Enrollment

260Estimated

Last Update Posted

Feb 6, 2025Actual

Start Date

Aug 23, 2024Actual

Primary Completion Date

Aug 1, 2025Estimated

Completion Date

Aug 1, 2025Estimated

Official Title

Long-term Evaluation of the Value of Using an MTor Inhibitor (everolimus) for the Minimisation of Anticalceurins in Old-for-old Kidney Transplantation

Brief Summary

Long Term Follow up of EVEROLD study

• Transplant; Complication, Failure

Ages Eligible for Study

Adult (18-64)Older Adult (65+)

Sexes Eligible for Study

All

Accepts Healthy Volunteers

No

Eligibility Criteria

Inclusion Criteria:

• Informed patients participating to the EVEROLD study
• Patient having completed the EVEROLD M12 follow-up visit
• Patient agreeing to participate in the observational study

Exclusion Criteria:

• Opposition to the use his medical data
• Patient under legal protection

Observational Model

Case-Only

Time Perspective

Retrospective

Lead Sponsor

University Hospital, BrestOTHER

lionel.couzi@chu-bordeaux.fr

yannick.lemeur@chu-brest.fr

marc.hazzan@univ-lille.fr03 20 44 59 62

jean-philippe.rerolle@chu-limoges.fr05 55 05 55 55

sicard.a@chu.nice.fr03 80 29 30 31

dany.anglicheau@aphp.fr01 44 49 40 00

antoine.thierry@chu-poitiers.fr05 49 44 44 44

elsa.vabret@chu-rennes.fr02 99 28 43 21 ext. +33

dominique.bertrand@chu-rouen.fr02 32 88 89 90

buchler@med.univ-tours.fr02 47 47 47 47